3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
5
Recurrence
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Prolymphocytic, T-Cell
2
Immunoblastic Lymphadenopathy
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia, Lymphoid
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Fulvestrant
5
serabelisib
2
sapanisertib
2
ribociclib
2
palbociclib
2
Paclitaxel
2
Letrozole
2
Irinotecan
2
Gemcitabine
2
Carboplatin
2
Alpelisib
2
venetoclax
1
tivozanib
1
tipifarnib
1
sotorasib
1
pembrolizumab
1
olaparib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
ceralasertib
1
cemiplimab
1
capivasertib
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
duvelisib
×
1 year
×
Clear all
No trials found.